Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125 USD | -0.47% | +17.72% | +25.69% |
05-03 | Jefferies Adjusts Price Target on Moderna to $155 From $125 | MT |
05-03 | Oppenheimer Adjusts Price Target on Moderna to $163 From $142 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B | |
+19.33% | 11.45B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna : says new results show its COVID-19 vaccine works well, and it will seek emergency regulatory OK in U.S., Europe